Medicare Enrolled

Dr. Abhishek Agarwal, MD

Pulmonary Disease · Marlton, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
RENAISSANCE SQUARE, 141 ROUTE 70, SUITE B, Marlton, NJ 08053
8565969057
Registered in NPPES since 2014
NPI: 1417365438 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Agarwal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Agarwal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Agarwal

Dr. Abhishek Agarwal is a pulmonary disease specialist in Marlton, NJ, with 12 years of NPI registration. Based on federal Medicare data, Dr. Agarwal performed 1,209 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Agarwal received a total of $4,267 from 34 pharmaceutical and/or device companies across 235 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Agarwal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years of NPI registration ▲ 1,209 Medicare services $4,267 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,209
Medicare services
Bottom 43% in NJ for pulmonary disease
Not available
Unique patients (not deduplicated)
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
344 $91 $193
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
312 $164 $460
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
172 $92 $187
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
82 $20 $65
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
62 $133 $362
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
46 $126 $292
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
36 $23 $95
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
28 $44 $105
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
27 $41 $115
Additional 30 minutes of critical care
This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period.
26 $80 $225
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
20 $20 $75
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
20 $61 $135
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
18 $101 $247
Low dose CT scan of chest for lung cancer screening
A specialized CT scan of the chest using a lower radiation dose to screen for lung cancer.
16 $140 $425
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,267
Total received (2018-2024)
Avg $610/year across 7 years
Top 37% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
235
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$651
2023
$982
2022
$993
2021
$959
2020
$373
2019
$180
2018
$130

Payments by company (2024)

GlaxoSmithKline, LLC.
$265
AstraZeneca Pharmaceuticals LP
$67
GENZYME CORPORATION
$47
Regeneron Healthcare Solutions, Inc.
$45
Mylan Specialty L.P.
$28
United Therapeutics Corporation
$25
ANI Pharmaceuticals, Inc.
$24
HARMONY BIOSCIENCES LLC
$23
Azurity Pharmaceuticals, Inc.
$21
Janssen Pharmaceuticals, Inc
$21
JAZZ PHARMACEUTICALS INC.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Amgen Inc.
$17
Baxter Healthcare
$17
Philips North America LLC
$16
Top 3 companies account for 58.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,176
AstraZeneca Pharmaceuticals LP
$727
GENZYME CORPORATION
$304
Boehringer Ingelheim Pharmaceuticals, Inc.
$236
Regeneron Healthcare Solutions, Inc.
$129
Actelion Pharmaceuticals US, Inc.
$126
E.R. Squibb & Sons, L.L.C.
$124
Genentech USA, Inc.
$123
Amgen Inc.
$119
Mylan Specialty L.P.
$111
Janssen Pharmaceuticals, Inc
$98
Baxter Healthcare
$88
PFIZER INC.
$83
Electromed, Inc.
$83
ANI Pharmaceuticals, Inc.
$77
JAZZ PHARMACEUTICALS INC.
$76
Insmed, Inc.
$68
Takeda Pharmaceuticals U.S.A., Inc.
$65
Novartis Pharmaceuticals Corporation
$58
SANOFI-AVENTIS U.S. LLC
$57
Advanced Respiratory, Inc
$57
Inogen, Inc.
$43
Mallinckrodt Hospital Products Inc.
$39
United Therapeutics Corporation
$25
HARMONY BIOSCIENCES LLC
$23
Paratek Pharmaceuticals, Inc.
$22
Azurity Pharmaceuticals, Inc.
$21
Harmony Biosciences LLC
$18
Merck Sharp & Dohme LLC
$18
Philips North America LLC
$16
Biohaven Pharmaceutical Holding Company Ltd.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Philips Electronics North America Corporation
$14
Novo Nordisk Inc
$13
Top 3 companies account for 51.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · ANORO ELLIPTA · ARALAST · AREXVY · Arikayce · BELSOMRA · BENLYSTA · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · DUPIXENT · ELIQUIS · FARXIGA · FASENRA · GLASSIA · HORIZANT · Hillrom - Vest System Model 105 Home Care · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · InogenOne · Life 2000 Ventilation System · NUCALA · NURTEC ODT · NUZYRA · OFEV · OPSUMIT · Ozempic · PREVNAR 13 · PURIFIED CORTROPHIN GEL · SMARTVEST · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · The Monarch Airway Clearance System · UPTRAVI · WAKIX · XARELTO · XIFAXAN · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Marlton?
Compare pulmonary diseases in the Marlton area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
241
County median income
$105,271
Nearest hospital to ZIP centroid (approximate)
WEISMAN CHILDRENS REHABILITATION HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Agarwal is a clinical cardiology specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Agarwal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Agarwal performed 344 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Agarwal receive payments from pharmaceutical companies?
Yes. Dr. Agarwal received a total of $4,267 from 34 companies across 235 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Agarwal's costs compare to other pulmonary diseases in Marlton?
Dr. Agarwal's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Agarwal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →